Development code · Small Molecule
ITI-1284-ODT-SL
ITI-1284-ODT-SL is a development code for ITI-1284 (deulumateperone), developed by Intra-Cellular Therapies, Inc..
- Status
- Phase 2 for Alzheimer's disease
- Mechanism
- 5-HT2A Antagonist
- Developer
- Intra-Cellular Therapies, Inc.
Programs
- ITI-1284 (deulumateperone) for Alzheimer's diseasePhase 2Recruiting
- ITI-1284 (deulumateperone) for Generalized anxiety disorderPhase 2Recruiting
- ITI-1284 (deulumateperone) for Agitation in Alzheimer's diseasePhase 2Recruiting
Also known as
- ITI-1284
- deulumateperone
- 2102683-75-8